102 related articles for article (PubMed ID: 38764295)
1. Downregulation of WNK4 expression facilitates the proliferation of gastric cancer cells via activation of the STAT3 signaling pathway.
Li M; Shao X; Ning Q; Sun R; Li R; Liu Y; Yuan Y; Zhang Y
Neoplasma; 2024 May; ():. PubMed ID: 38764295
[TBL] [Abstract][Full Text] [Related]
2. 18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3.
Yang Y; Nan Y; Du YH; Huang SC; Lu DD; Zhang JF; Li X; Chen Y; Zhang L; Yuan L
World J Gastroenterol; 2023 Jul; 29(27):4317-4333. PubMed ID: 37545635
[TBL] [Abstract][Full Text] [Related]
3. Loss of miR-26b-5p promotes gastric cancer progression via miR-26b-5p-PDE4B/CDK8-STAT3 feedback loop.
Xu T; Xie M; Jing X; Jiang H; Wu X; Wang X; Shu Y
J Transl Med; 2023 Feb; 21(1):77. PubMed ID: 36737782
[TBL] [Abstract][Full Text] [Related]
4. Obesity Attenuates Ventilator-Induced Lung Injury by Modulating the STAT3-SOCS3 Pathway.
Wu SW; Peng CK; Wu SY; Wang Y; Yang SS; Tang SE; Huang KL
Front Immunol; 2021; 12():720844. PubMed ID: 34489970
[TBL] [Abstract][Full Text] [Related]
5. Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic JAK2/STAT3 signaling: In vitro and in vivo therapeutic intervention.
He P; Li Y; Hu J; Deng B; Tan Z; Chen Y; Yu B; Dong W
Phytomedicine; 2024 Jun; 128():155316. PubMed ID: 38518635
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway.
San-Cristobal P; Pacheco-Alvarez D; Richardson C; Ring AM; Vazquez N; Rafiqi FH; Chari D; Kahle KT; Leng Q; Bobadilla NA; Hebert SC; Alessi DR; Lifton RP; Gamba G
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4384-9. PubMed ID: 19240212
[TBL] [Abstract][Full Text] [Related]
7. Human epidermal growth factor receptor 2 expressions and Janus-activated kinase/signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway may be associated with clinicopathological features and prognosis of gastric cancer.
Xu W; Fu J; Wu H; Sun W
J Cancer Res Ther; 2018 Jun; 14(Supplement):S311-S318. PubMed ID: 29970682
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway.
Liang W; Xia B; He C; Zhai G; Li M; Zhou J
Int J Biochem Cell Biol; 2020 Jun; 123():105751. PubMed ID: 32330554
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0000117 accelerates the proliferation and invasion of gastric cancer cells by regulating the microRNA-337-3p/signal transducer and activator of transcription 3 axis.
Gao Q; Liu Q; Chen H
Bioengineered; 2021 Dec; 12(1):1381-1390. PubMed ID: 33896365
[TBL] [Abstract][Full Text] [Related]
11. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
[TBL] [Abstract][Full Text] [Related]
12. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
[TBL] [Abstract][Full Text] [Related]
13. miR-125a restrains cell migration and invasion by targeting STAT3 in gastric cancer cells.
Yang L; Zhang S; Guo K; Huang H; Qi S; Yao J; Zhang Z
Onco Targets Ther; 2019; 12():205-215. PubMed ID: 30636883
[TBL] [Abstract][Full Text] [Related]
14. C-terminal of E1A binding protein 1 enhances the migration of gastric epithelial cells and has a clinicopathologic significance in human gastric carcinoma.
Wang C; Wang M; Xing B; Chi Z; Wang H; Lie C; Dong H
Onco Targets Ther; 2019; 12():5189-5200. PubMed ID: 31308691
[TBL] [Abstract][Full Text] [Related]
15. WNK4 kinase inhibits Maxi K channel activity by a kinase-dependent mechanism.
Zhuang J; Zhang X; Wang D; Li J; Zhou B; Shi Z; Gu D; Denson DD; Eaton DC; Cai H
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F410-9. PubMed ID: 21613417
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor ATF2 promotes gastric cancer progression by activating the METTL3/cyclin D1 pathway.
Meng H; Li J; Sun H; Lin Y; Xu H; Zhang N
Drug Dev Res; 2023 Sep; 84(6):1325-1334. PubMed ID: 37421203
[TBL] [Abstract][Full Text] [Related]
17. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis.
Deng P; Sun M; Zhao WY; Hou B; Li K; Zhang T; Gu F
World J Gastroenterol; 2021 Feb; 27(6):487-500. PubMed ID: 33642823
[TBL] [Abstract][Full Text] [Related]
19. C-terminally truncated, kidney-specific variants of the WNK4 kinase lack several sites that regulate its activity.
Murillo-de-Ozores AR; Rodríguez-Gama A; Bazúa-Valenti S; Leyva-Ríos K; Vázquez N; Pacheco-Álvarez D; De La Rosa-Velázquez IA; Wengi A; Stone KL; Zhang J; Loffing J; Lifton RP; Yang CL; Ellison DH; Gamba G; Castañeda-Bueno M
J Biol Chem; 2018 Aug; 293(31):12209-12221. PubMed ID: 29921588
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-CCAT5-mediated crosstalk between Wnt/β-Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity.
Liu C; Shen A; Song J; Cheng L; Zhang M; Wang Y; Liu X
Cancer Commun (Lond); 2024 Jan; 44(1):76-100. PubMed ID: 38010289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
